Relationship between skeletal muscle mass index and metabolic phenotypes of obesity in adolescents
TONG Ling-Ling1,2, MA Xiao-Yan1,2, TIAN Mei1,2, DING Wen-Qing1,2
.School of Public Health and Management, Ningxia Medical University, Yinchuan 750004, .Key Laboratory of Environment and Chronic Disease Control in Ningxia, Yinchuan 750004, China
Abstract:Objective To study the relationship between skeletal muscle mass index (SMI) and metabolic phenotypes of obesity in adolescents, and to provide a basis for the prevention and control of adolescent obesity and related metabolic diseases. Methods A total of 1 352 adolescents aged 12 to 18 years were randomly selected by stratified cluster sampling in Yinchuan City from October 2017 to September 2020, and they were surveyed using questionnaires, physical measurements, body composition measurements, and laboratory tests. According to the diagnostic criteria for metabolic abnormalities and the definition of obesity based on the body mass index, the subjects were divided into four metabolic phenotypes: metabolically healthy normal weight, metabolically healthy obesity, metabolically unhealthy normal weight, and metabolically unhealthy obesity. The association between SMI and the metabolic phenotypes was analyzed using multivariate logistic regression. Results The SMI level in the metabolically unhealthy normal weight, metabolically healthy obesity, and metabolically unhealthy obesity groups was lower than that in the metabolically healthy normal weight group (P<0.001). Multivariate logistic regression analysis showed that after adjusting for gender and age, a higher SMI level was a protective factors for adolescents to develop metabolic unhealthy normal weight, metabolically healthy obesity, and metabolically unhealthy obesity phenotypes (OR=0.74, 0.60, and 0.54, respectively; P<0.001). Conclusions Increasing SMI can reduce the risk of the development of metabolic unhealthy/obesity.
TONG Ling-Ling,MA Xiao-Yan,TIAN Mei et al. Relationship between skeletal muscle mass index and metabolic phenotypes of obesity in adolescents[J]. CJCP, 2023, 25(5): 457-462.
Lin H, Zhang L, Zheng R, et al. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: a PRISMA-compliant article[J]. Medicine (Baltimore), 2017, 96(47): e8838. PMID: 29381992. PMCID: PMC5708991. DOI: 10.1097/MD.0000000000008838.
Stefan N, H?ring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?[J]. Lancet Diabetes Endocrinol, 2018, 6(3): 249-258. PMID: 28919065. DOI: 10.1016/S2213-8587(17)30292-9.
Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies[J]. Obes Rev, 2014, 15(6): 504-515. PMID: 24661566. PMCID: PMC4309497. DOI: 10.1111/obr.12157.
Stefan N, H?ring HU, Hu FB, et al. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications[J]. Lancet Diabetes Endocrinol, 2013, 1(2): 152-162. PMID: 24622321. DOI: 10.1016/S2213-8587(13)70062-7.
Kim TN, Park MS, Yang SJ, et al. Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS)[J]. J Clin Endocrinol Metab, 2013, 98(2): 811-817. PMID: 23293328. DOI: 10.1210/jc.2012-3292.
Hwang YC, Cho IJ, Jeong IK, et al. Differential association between sarcopenia and metabolic phenotype in Korean young and older adults with and without obesity[J]. Obesity (Silver Spring), 2017, 25(1): 244-251. PMID: 27874274. DOI: 10.1002/oby.21694.
Zhang H, Lin S, Gao T, et al. Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis[J]. Nutrients, 2018, 10(3): 364. PMID: 29547573. PMCID: PMC5872782. DOI: 10.3390/nu10030364.
Lee MJ, Kim EH, Bae SJ, et al. Protective role of skeletal muscle mass against progression from metabolically healthy to unhealthy phenotype[J]. Clin Endocrinol (Oxf), 2019, 90(1): 102-113. PMID: 30290006. DOI: 10.1111/cen.13874.
Poggiogalle E, Lubrano C, Gnessi L, et al. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity[J]. Clin Nutr, 2019, 38(5): 2430-2435. PMID: 30792144. DOI: 10.1016/j.clnu.2019.01.028.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents[J]. Pediatrics, 2004, 114(2 Suppl 4th Report): 555-576. PMID: 15286277.
Kim HK, Lee MJ, Kim EH, et al. Comparison of muscle mass and quality between metabolically healthy and unhealthy phenotypes[J]. Obesity (Silver Spring), 2021, 29(8): 1375-1386. PMID: 34235892. DOI: 10.1002/oby.23190.
Carvalho CJ, Longo GZ, Kakehasi AM, et al. Skeletal mass indices are inversely associated with metabolically unhealthy phenotype in overweight/obese and normal-weight men: a population-based cross-sectional study[J]. Br J Nutr, 2021, 126(4): 501-509. PMID: 33143771. DOI: 10.1017/S0007114520004262.
Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance[J]. Nat Med, 2000, 6(8): 924-928. PMID: 10932232. DOI: 10.1038/78693.
Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice[J]. J Clin Invest, 2008, 118(3): 829-838. PMID: 18317565. PMCID: PMC2254980. DOI: 10.1172/JCI34275.
Tuttle CSL, Thang LAN , Maier AB. Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis[J]. Ageing Res Rev, 2020, 64: 101185. PMID: 32992047. DOI: 10.1016/j.arr.2020.101185.
Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction[J]. FASEB J, 2005, 19(6): 668-670. PMID: 15665035. DOI: 10.1096/fj.04-2870fje.